Prolonged Neurocognitive Consequences of COVID-19 in Workers from the Escuela Politécnica del Litoral of Ecuador
Keywords:
síndrome post-agudo COVID-19, deterioro, funciones ejecutivasAbstract
Background: Post-SARS-CoV-2 recovery, individuals often experience anxiety, depression, insomnia, and cognitive disorders such as attention and memory deficits, persisting for weeks. Objective: evaluate cognitive performance, through memory and executive functions in young adults, 12 weeks after recovering from COVID-19 infection. Method: A retrospective case-control observational study was conducted with 40 COVID-19 recovered subjects and 13 non-infected individuals. The study evaluated executive functions, memory, and attention 12 weeks post-recovery. Results: The findings reveal that recovered COVID-19 patients exhibit decreased processing speed, increased omission of stimuli, slower reaction times, and impaired ability to recall visuospatial stimuli compared to uninfected individuals. These cognitive deficits were noted weeks following recovery from COVID-19's acute phase. Conclusions: Recovered individuals show significant cognitive function alterations, particularly in attention and executive functions, 12 weeks post-acute phase. Early detection of these impairments is crucial for timely intervention, essential to prevent further cognitive decline. The study highlights the necessity of prospective research to understand the long-term effects of COVID-19 on previously infected adults. Such insights are vital for developing strategies to maintain the mental health of this population.Downloads
References
2. Mcloughlin BC, Miles A, Webb TE, et al. Functional and cognitive outcomes after COVID-19 delirium. Eur Geriatr Med. 2020;11(5):857-862. Available in: https://doi.org/10.1007/s41999-020-00353-8.
3. Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study. Lancet. 2020;395(10223):507-513. Available in: https://doi.org/10.1016/s0140-6736(20)30211-7.
4. Ramage AE. Potential for cognitive communication impairment in COVID-19 survivors: A call to action for speech-language pathologists. Am J Speech-Language Pathol. 2020;29(4):1821-1832. Available in: https://doi.org/10.1044/2020_ajslp-20-00147
5. Carfì A, Bernabei R, Landi F. Persistent symptoms in patients after acute COVID-19. JAMA. 2020;324(6):603-605. Available in: https://doi.org/10.1001/jama.2020.12603
6. Huang C, Huang L, Wang Y, et al. RETRACTED: 6-month consequences of COVID-19 in patients discharged from hospital: A cohort study. Lancet. 2021;397(10270):220-232. Available in: https://doi.org/10.1016/s0140-6736(20)32656-8
7. Thakur N, Blanc PD, Julian L, et al. COPD and cognitive impairment: The role of hypoxemia and oxygen therapy. C25. Chronic obstructive pulmonary disease: Updates on epidemiology and clinical phenotypes. Am J Respir Crit Care Med. 2010 May. Available in: http://dx.doi.org/10.1164/ajrccm-
conference.2010.181.1_meetingabstracts.a4125
8. Seisdedos N. d2-R. Test de Atención [Internet]. Revisado. 2012. Available in: https://web.teaediciones.com/d2-R-Test-de-Atencion---Revisado.aspx
9. Tulving E. Memory and consciousness. Can Psychol. 1985;26(1):1-12. Available in: https://doi.org/10.1037/h0080017
10. Henríquez ML de los MC. Variantes genéticas asociadas al trastorno por déficit de atención e hiperactividad en una comunidad del Caribe colombiano. Universidad del Norte. 2022. Available in: http://hdl.handle.net/10584/11514
11. Ostrosky-Solís F, Ardila A, Rosselli M. NEUROPSI: A brief neuropsychological test battery in Spanish with norms by age and educational level. J Int Neuropsychol Soc. 1999;5(5):413-433. Available in: https://doi.org/10.1017/s1355617799555045
12. Stroop JR. Studies of interference in serial verbal reactions. J Exp Psychol. 1935;18(6):643-662. Available in: https://doi.org/10.1037/h0054651
13. Becker JH, Lin JJ, Doernberg M, et al. Assessment of cognitive function in patients after COVID-19 infection. JAMA Netw Open. 2021;4(10):e2130645. Available in: https://doi.org/10.1001/jamanetworkopen.2021.30645
14. Vialatte de Pémille C, Ray A, Michel A, et al. Prevalence and prospective evaluation of cognitive dysfunctions after SARS due to SARS-CoV-2 virus. The CognitiVID study. Rev Neurol (Paris). 2022;178(8):802-807. Available in: https://doi.org/10.1016/j.neurol.2022.03.014
15. Guo P, Benito Ballesteros A, Yeung SP, et al. COVCOG 2: Cognitive and memory deficits in long COVID: A second publication from the COVID and cognition study. Front Aging Neurosci. 2022;14. Available in: https://doi.org/10.3389/fnagi.2022.804937
16. García-Sánchez C, Calabria M, Grunden N, et al. Neuropsychological deficits in patients with cognitive complaints after COVID-19. Brain Behav. 2022;12(3). Available in: https://doi.org/10.1002/brb3.2508
17. Delgado-Alonso C, Valles-Salgado M, Delgado-Álvarez A, et al. Cognitive dysfunction associated with COVID-19: A comprehensive neuropsychological study. J Psychiatr Res. 2022;150:40-46. Available in: https://doi.org/10.1016/j.jpsychires.2022.03.033
18. Ariza M, Cano N, Segura B, et al. Neuropsychological impairment in post-COVID condition individuals with and without cognitive complaints. Front Aging Neurosci. 2022;14. Available in: https://doi.org/10.3389/fnagi.2022.1029842
19. Daroische R, Hemminghyth MS, Eilertsen TH, Breitve MH, Chwiszczuk LJ. Cognitive impairment after COVID-19—A review on objective test data. Front Neurol. 2021;12. Available in: https://doi.org/10.3389/fneur.2021.699582
20. Delgado-Alonso C, Valles-Salgado M, Delgado-Álvarez A, et al. Cognitive dysfunction associated with COVID-19: A comprehensive neuropsychological study. J Psychiatr Res. 2022;150:40-46. Available in: https://doi.org/10.1016/j.jpsychires.2022.03.033